PRESS RELEASE published on 03/07/2025 at 08:29, 1 year ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics announces c. €0.9 million financing round for innovative gene therapy program. Financing from existing investors supports LUMEVOQ access for patients. Business update includes 2024 annual results and working capital statement Financing Business Update Gene Therapy GenSight Biologics LUMEVOQ
PRESS RELEASE published on 03/07/2025 at 08:29, 1 year ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) GenSight Biologics annonce un financement de 0,9 million d'euros auprès d'investisseurs existants. Augmentation de capital pour avancer ses recherches thérapeutiques essentielles Financement GenSight Biologics Thérapies Géniques Investisseurs Existants Recherche Thérapeutique
BRIEF published on 02/27/2025 at 09:02, 1 year ago GenSight Biologics : Résultats Financiers 2024 et Perspectives Résultats Financiers 2024 Gestion De Trésorerie Financement Futur Térapie Génique Accès Compassionnel LUMEVOQ
BRIEF published on 02/27/2025 at 09:02, 1 year ago GenSight Biologics: 2024 Financial Results and Outlook Gene Therapy Cash Management Financial Results 2024 Future Financing LUMEVOQ Compassionate Access
PRESS RELEASE published on 02/27/2025 at 08:57, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie ses résultats financiers estimés pour l'année 2024. L'entreprise prolonge son horizon de trésorerie jusqu'à avril 2025 grâce à une gestion rigoureuse et au Crédit d'Impôt Recherche Résultats Financiers Trésorerie GenSight Biologics Crédit D'Impôt Recherche AAC
PRESS RELEASE published on 02/27/2025 at 08:57, 1 year ago Inside Information / News release on accounts, results GenSight Biologics reports estimated full-year 2024 consolidated financial results. Cash runway extended to early April 2025. Resumption of Compassionate Access Program expected in April 2025 Financial Results 2024 GenSight Biologics Cash Runway Compassionate Access Program
BRIEF published on 02/12/2025 at 07:35, 1 year 1 month ago GenSight Biologics Reports Positive Five-Year Outcomes for LUMEVOQ® Gene Therapy Gene Therapy LUMEVOQ® Visual Acuity Safety Profile REFLECT Study
BRIEF published on 02/12/2025 at 07:35, 1 year 1 month ago GenSight Biologics annonce des résultats positifs sur cinq ans pour la thérapie génique LUMEVOQ® Thérapie Génique LUMEVOQ® Acuité Visuelle Profil De Sécurité Étude REFLECT
PRESS RELEASE published on 02/12/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases GenSight Biologics reports 5-year efficacy and safety results for LUMEVOQ® gene therapy in REFLECT study with sustained visual improvement and favorable safety profile Gene Therapy GenSight Biologics LUMEVOQ Visual Acuity REFLECT Study
PRESS RELEASE published on 02/12/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués GenSight Biologics annonce les résultats à 5 ans de la thérapie génique LUMEVOQ® pour la NOHL, confirmant l'efficacité durable et le profil de sécurité favorable Sécurité Efficacité Thérapie Génique GenSight Biologics LUMEVOQ
Published on 03/24/2026 at 23:00, 5 hours 17 minutes ago Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Published on 03/24/2026 at 18:55, 9 hours 22 minutes ago Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 14 hours 47 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 14 hours 47 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 21:08, 7 hours 9 minutes ago Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 8 hours 28 minutes ago EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 8 hours 35 minutes ago ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 9 hours 12 minutes ago WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 9 hours 37 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 17:46, 10 hours 31 minutes ago NRJ GROUP - Press release annual results 2025
